Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Koninklijke Philips ( (PHG) ) just unveiled an announcement.
On February 21, 2025, Koninklijke Philips published its 2024 Annual Report, highlighting significant strides in healthcare innovation and operational improvements. Philips reported achievements in patient safety and quality, enhanced employee engagement, and strategic collaborations to improve patient monitoring and care delivery. The report emphasized the company’s progress on its three-year plan, with a focus on innovation and sustainability, including the introduction of next-generation MRI systems and AI-enabled ultrasound platforms. Financially, Philips noted a stable credit rating outlook and reported sales of EUR 18.0 billion with an adjusted EBITA margin of 11.5%. The advancements reflect Philips’ commitment to impacting patient care and supporting healthcare professionals, positioning the company strongly within the health technology industry.
More about Koninklijke Philips
Koninklijke Philips, also known as Royal Philips, is a leading health technology company based in the Netherlands. The company specializes in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as consumer health and home care products. Philips is focused on improving people’s health and well-being through meaningful innovation, with a strong emphasis on patient safety and quality.
YTD Price Performance: 0.20%
Average Trading Volume: 618,340
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $23.48B
See more insights into PHG stock on TipRanks’ Stock Analysis page.
